{"article_title": "Excellere Partners Invests in Pharma Support Group TrialCard", "article_keywords": ["firm", "partners", "group", "pharma", "pharmaceutical", "support", "companies", "sk", "health", "services", "invests", "excellere", "halo", "trialcard"], "article_url": "http://www.themiddlemarket.com/news/healthcare/excellere-partners-invests-in-pharma-support-group-trialcard-254337-1.html", "article_text": "Excellere Partners Invests in Pharma Support Group TrialCard\n\nThe deal was announced on the heels of SK Capital's purchase of Halo Pharmaceutical\n\nExcellere Partners has made an undisclosed investment in in TrialCard Inc.\n\nTrialCard, headquartered in Cary, North Carolina, provides pharmaceutical marketing and customer support services. The company processes about $1 billion in patient benefits per year.\n\nExcellere is a Denver-based private equity firm that has about $737 million in committed capital. The firm plans to help TrialCard grow organically and through acquisitions. The firm has invested in other health care-related companies, including AxelaCare, which it sold to Harvest Partners LP in April 2013. Excellere's current portfolio companies include Advanced Pain Management, Advanced Infusion Solutions and U.S. Water Services.\n\nHarris Williams & Co. advised TrialCard on the deal.\n\nOther pharmaceutical services companies have also been acquisition targets. Earlier in January, SK Capital Partners bought a majority stake in Halo Pharmaceutical. For more on health care, see 5 Technologies That Drove Health Care M&A in 2014.\n\nFor more information on related topics, visit the following:", "article_metadata": {"og": {"url": "http://www.themiddlemarket.com/news/healthcare/excellere-partners-invests-in-pharma-support-group-trialcard-254337-1.html", "image": "http://cdn.themiddlemarket.com/media/newspics/business-stock-image.jpg", "site_name": "Mergers & Acquisitions, Latest News", "title": "Excellere Partners Invests in Pharma Support Group TrialCard"}}, "_id": "\"57477af36914bd0286fd0632\"", "article_summary": "Excellere Partners Invests in Pharma Support Group TrialCardThe deal was announced on the heels of SK Capital's purchase of Halo PharmaceuticalExcellere Partners has made an undisclosed investment in in TrialCard Inc.TrialCard, headquartered in Cary, North Carolina, provides pharmaceutical marketing and customer support services.\nOther pharmaceutical services companies have also been acquisition targets.\nEarlier in January, SK Capital Partners bought a majority stake in Halo Pharmaceutical.\nThe firm has invested in other health care-related companies, including AxelaCare, which it sold to Harvest Partners LP in April 2013.\nExcellere is a Denver-based private equity firm that has about $737 million in committed capital."}